Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 43: 195-196, 1997;
This Article
Right arrow Full Text
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panteghini, M.
Right arrow Articles by Pagani, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panteghini, M.
Right arrow Articles by Pagani, F.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1997;43:195-196.)
© 1997 American Association for Clinical Chemistry, Inc.

Letters

Automated Immunoassay of Cardiac Troponin I in Serum Evaluated

Mauro Panteghinia, Roberto Bonora and Franca Pagani

1st Lab. Clin. Chem., Clin. Chem. and Enzymol. Section, Spedali Civili, 25125 Brescia, Italy
a Author for correspondence.


To the Editor:

We evaluated the Opus Troponin I assay (Behring Diagnostics, Westwood, MA), a two-site sandwich, fluorogenic ELISA that uses two goat polyclonal antibodies directed against different protein segments unique to cardiac troponin I (cTnI) (1). Pipetting, incubations, measurements, and data-reduction steps are performed on the Opus analyzer; the first test result requires 20 min. The assay measures concentrations of cTnI in serum as great as ~135 µg/L.

The calibration appeared to be stable for at least 4 weeks. Serial dilution of a human serum sample with a high concentration of cTnI showed no significant curvature when the curve obtained was tested for linearity [quadratic regression: y = -0.25 + 96.1x + 6.31x2, with the coefficient of x2 not significantly different from 0 (P = 0.27)] (2). Linear regression analysis of these data confirmed the high linearity of the response (r = 0.9998). The minimum detectable cTnI concentration, assessed by . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. Labugger, J. A. Simpson, M. Quick, H. A. Brown, C. E. Collier, I. Neverova, and J. E. Van Eyk
Strategy for Analysis of Cardiac Troponins in Biological Samples with a Combination of Affinity Chromatography and Mass Spectrometry
Clin. Chem., June 1, 2003; 49(6): 873 - 879.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. J. Newman, Y. Olabiran, W. D. Bedzyk, S. Chance, E. G. Gorman, and C. P. Price
Impact of Antibody Specificity and Calibration Material on the Measure of Agreement between Methods for Cardiac Troponin I
Clin. Chem., June 1, 1999; 45(6): 822 - 828.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Panteghini, R. Bonora, F. Pagani, F. Buffoli, and C. Cuccia
Rapid, Highly Sensitive Immunoassay for Determination of Cardiac Troponin I in Patients with Myocardial Cell Damage
Clin. Chem., August 1, 1997; 43(8): 1464 - 1465.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.